Skip to main content
Top
Published in: Journal of Translational Medicine 1/2018

Open Access 01-12-2018 | Research

OX40L induces helper T cell differentiation during cell immunity of asthma through PI3K/AKT and P38 MAPK signaling pathway

Authors: Li Huang, Meijuan Wang, Yongdong Yan, Wenjing Gu, Xinxing Zhang, Jiahong Tan, Huiming Sun, Wei Ji, Zhengrong Chen

Published in: Journal of Translational Medicine | Issue 1/2018

Login to get access

Abstract

Background

The aim of this study was to investigate the mechanisms of OX40L in regulating helper T (Th) cells differentiation through phosphoinositide 3-kinase (PI3K)/AKT and p38 mitogen-activated protein kinase signaling pathway in vitro and in vivo experiments.

Methods

Serum samples of patients with asthma and healthy controls were used to explore the association between OX40L and Th cells. Enzyme-linked immunosorbent assay (ELISA) was used to measure the serum concentrations of OX40L, IL-4, IFN-γ, IL-17 and TGF-β. Flow cytometry method was used to analyze Th1, Th2, Th17 and Treg cells. 3H-thymidine was used to determine the proliferation of T cells. Western Blot was used to detect protein expression and phosphorylation. Immunohistochemistry was used to detect the expression of OX40L in lung tissues.

Results

OX40L, IL-4, IL-17 increased in patient serum compared to healthy control and in the ovalbumin (OVA)-primed mononuclear cells compared to normal cells, while IFN-γ and TGF-β were decreased. Besides, the OVA-primed CD4+ T cells treated with OX40L-Ig fusion protein promoted the proliferation of T cells and Th2 and Th17 cells differentiation as well as PI3K/AKT and p38 MAPK signaling pathway, but suppressed Th1 and Treg cells differentiation. Moreover, helper T cells differentiation in OVA-primed CD4+ T cells could be markedly reversed by the addition of PI3K/AKT inhibition, p38 MAPK inhibition and anti-OX40L monoclonal antibody.

Conclusions

In this study, we revealed that OX40L could regulate differentiation of helper T cells via PI3K/AKT and p38 MAPK signaling pathway in asthma. Besides, blockade of OX40/OX40L could inhibit the proliferation of CD4+ T cells and regulate polarization of helper T cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siddiqui S, Mistry V, Doe C, Stinson S, Foster M, Brightling C. Airway wall expression of OX40/OX40L and interleukin-4 in asthma. Chest. 2010;137:797–804.CrossRefPubMedPubMedCentral Siddiqui S, Mistry V, Doe C, Stinson S, Foster M, Brightling C. Airway wall expression of OX40/OX40L and interleukin-4 in asthma. Chest. 2010;137:797–804.CrossRefPubMedPubMedCentral
2.
go back to reference Wang YH, Ito T, Wang YH, Homey B, Watanabe N, Martin R, et al. Maintenance and polarization of human T H 2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity. 2006;24:827–38.CrossRefPubMed Wang YH, Ito T, Wang YH, Homey B, Watanabe N, Martin R, et al. Maintenance and polarization of human T H 2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity. 2006;24:827–38.CrossRefPubMed
3.
go back to reference De ST, Smith J, Baum P, Fanslow W, Butz E, Maliszewski C. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. J Immunol. 2002;168:661–70.CrossRef De ST, Smith J, Baum P, Fanslow W, Butz E, Maliszewski C. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. J Immunol. 2002;168:661–70.CrossRef
4.
go back to reference Ohshima Y, Yang LP, Uchiyama T, Tanaka Y, Baum P, Sergerie M, et al. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood. 1998;92:3338–45.PubMed Ohshima Y, Yang LP, Uchiyama T, Tanaka Y, Baum P, Sergerie M, et al. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood. 1998;92:3338–45.PubMed
5.
go back to reference Ogawa R, Lee S, Kagiya G, Hirano H, Fukuda S, Kondol T, et al. Immune regulation and control of regulatory T cells by OX40 and 4-1BB. Cytokine Growth Factor Rev. 2008;19:253–62.CrossRef Ogawa R, Lee S, Kagiya G, Hirano H, Fukuda S, Kondol T, et al. Immune regulation and control of regulatory T cells by OX40 and 4-1BB. Cytokine Growth Factor Rev. 2008;19:253–62.CrossRef
6.
go back to reference Paterson DJ, Jefferies WA, Green JR, Brandon MR, Corthesy P, Puklavec M, et al. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol. 1987;24:1281–90.CrossRefPubMed Paterson DJ, Jefferies WA, Green JR, Brandon MR, Corthesy P, Puklavec M, et al. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol. 1987;24:1281–90.CrossRefPubMed
8.
go back to reference Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8:223–46.PubMed Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8:223–46.PubMed
9.
go back to reference Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Immunology. 1989;7:145–73.CrossRef Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Immunology. 1989;7:145–73.CrossRef
10.
go back to reference Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180:388–95.CrossRefPubMedPubMedCentral Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180:388–95.CrossRefPubMedPubMedCentral
11.
12.
go back to reference Shi YH, Shi GC, Wan HY, Jiang LH, Ai XY, Zhu HX, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin Med J. 2011;124:1951–6.PubMed Shi YH, Shi GC, Wan HY, Jiang LH, Ai XY, Zhu HX, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin Med J. 2011;124:1951–6.PubMed
13.
go back to reference Zhao J, Lloyd CM, Noble A. Th17 responses in chronic allergic airway inflammation abrogate regulatory T cell-mediated tolerance and contribute to airway remodeling. Mucosal Immunol. 2012;6:335–46.CrossRefPubMedPubMedCentral Zhao J, Lloyd CM, Noble A. Th17 responses in chronic allergic airway inflammation abrogate regulatory T cell-mediated tolerance and contribute to airway remodeling. Mucosal Immunol. 2012;6:335–46.CrossRefPubMedPubMedCentral
14.
go back to reference Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy. 2011;66:989–98.CrossRefPubMed Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F. Th17 cells: new players in asthma pathogenesis. Allergy. 2011;66:989–98.CrossRefPubMed
15.
go back to reference Langier S, Sade K, Kivity S. Regulatory T cells in allergic asthma. Israel Med Assoc J. 2012;14:180–3. Langier S, Sade K, Kivity S. Regulatory T cells in allergic asthma. Israel Med Assoc J. 2012;14:180–3.
16.
go back to reference Haddad C, Bhattacharya P, Prabhakar B. Role of OX40/OX40L signaling in the expansion of regulatory T cells in the NOD mouse model (BA13P.127). J Immunol. 2014;192:177–213. Haddad C, Bhattacharya P, Prabhakar B. Role of OX40/OX40L signaling in the expansion of regulatory T cells in the NOD mouse model (BA13P.127). J Immunol. 2014;192:177–213.
18.
go back to reference Liu J, Chen JW, Yong-Jian XU, Xiong WN, Bai J, Xie M, et al. Expression of PI3K in airway smooth muscle cell of asthmatic rats. Chin J Pathophysiol. 2008;24:636–9. Liu J, Chen JW, Yong-Jian XU, Xiong WN, Bai J, Xie M, et al. Expression of PI3K in airway smooth muscle cell of asthmatic rats. Chin J Pathophysiol. 2008;24:636–9.
19.
go back to reference Wang J, Li F, Yang M, Wu J, Zhao J, Gong W, et al. FIZZ1 promotes airway remodeling through the PI3K/Akt signaling pathway in asthma. Exp Ther Med. 2014;7:1265–70.CrossRefPubMedPubMedCentral Wang J, Li F, Yang M, Wu J, Zhao J, Gong W, et al. FIZZ1 promotes airway remodeling through the PI3K/Akt signaling pathway in asthma. Exp Ther Med. 2014;7:1265–70.CrossRefPubMedPubMedCentral
20.
go back to reference Duan W, Aguinaldo Datiles AM, Leung BP, Vlahos CJ, Wong WS. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol. 2005;5:495–502.CrossRefPubMed Duan W, Aguinaldo Datiles AM, Leung BP, Vlahos CJ, Wong WS. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol. 2005;5:495–502.CrossRefPubMed
21.
go back to reference Langlois A, Chouinard F, Flamand N, Ferland C, Rola-Pleszczynski M, Laviolette M. Crucial implication of protein kinase C (PKC)-8, PKC-ζ, ERK-1/2, and p38 MAPK in migration of human asthmatic eosinophils. J Leukoc Biol. 2009;85:656–63.CrossRefPubMed Langlois A, Chouinard F, Flamand N, Ferland C, Rola-Pleszczynski M, Laviolette M. Crucial implication of protein kinase C (PKC)-8, PKC-ζ, ERK-1/2, and p38 MAPK in migration of human asthmatic eosinophils. J Leukoc Biol. 2009;85:656–63.CrossRefPubMed
22.
go back to reference Munoz L, Ramsay EE, Manetsch M, Ge Q, Peifer C, Laufer S, et al. p38 MAPK inhibitor, ML3403, SB203580, asthma. Eur J Pharmacol. 2010;635:212.CrossRefPubMed Munoz L, Ramsay EE, Manetsch M, Ge Q, Peifer C, Laufer S, et al. p38 MAPK inhibitor, ML3403, SB203580, asthma. Eur J Pharmacol. 2010;635:212.CrossRefPubMed
23.
go back to reference Ishii N, Takahashi T, Soroosh P, Sugamura K. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol. 2010;105:63–98.CrossRefPubMed Ishii N, Takahashi T, Soroosh P, Sugamura K. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol. 2010;105:63–98.CrossRefPubMed
24.
go back to reference Tsukada N, Akiba H, Kobata T, Aizawa Y, Yagita H, Okumura K. Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation. Blood. 2000;95:2434–9.PubMed Tsukada N, Akiba H, Kobata T, Aizawa Y, Yagita H, Okumura K. Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation. Blood. 2000;95:2434–9.PubMed
25.
go back to reference Ito T, Inoue K, Nishimura N, Takano H. Phthalate esters modulate the differentiation and maturation of mouse peripheral blood mononuclear cell-derived dendritic cells. J Appl Toxicol. 2012;32:142–8.CrossRefPubMed Ito T, Inoue K, Nishimura N, Takano H. Phthalate esters modulate the differentiation and maturation of mouse peripheral blood mononuclear cell-derived dendritic cells. J Appl Toxicol. 2012;32:142–8.CrossRefPubMed
26.
go back to reference Kamachi F, Harada N, Usui Y, Sakanishi T, Ishii N, Okumura K, et al. OX40 ligand regulates splenic CD8− dendritic cell-induced Th2 responses in vivo. Biochem Biophys Res Commun. 2014;444:235–40.CrossRefPubMed Kamachi F, Harada N, Usui Y, Sakanishi T, Ishii N, Okumura K, et al. OX40 ligand regulates splenic CD8− dendritic cell-induced Th2 responses in vivo. Biochem Biophys Res Commun. 2014;444:235–40.CrossRefPubMed
27.
go back to reference Naura AS, Zerfaoui M, Kim H, Elmageed ZYA, Rodriguez PC, Hans CP, et al. Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation. J Immunol. 2011;185:3076–85.CrossRef Naura AS, Zerfaoui M, Kim H, Elmageed ZYA, Rodriguez PC, Hans CP, et al. Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation. J Immunol. 2011;185:3076–85.CrossRef
28.
go back to reference Yadav UC, Naura AS, Aguileraaguirre L, Boldogh I, Boulares HA, Calhoun WJ, et al. Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice. PLoS ONE. 2013;8:e57442.CrossRefPubMedPubMedCentral Yadav UC, Naura AS, Aguileraaguirre L, Boldogh I, Boulares HA, Calhoun WJ, et al. Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice. PLoS ONE. 2013;8:e57442.CrossRefPubMedPubMedCentral
29.
go back to reference Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev. 1998;50:515–96.PubMed Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev. 1998;50:515–96.PubMed
30.
31.
go back to reference Ezzat MH, Imam SS, Shaheen KY, Elbrhami EM. Serum OX40 ligand levels in asthmatic children: a potential biomarker of severity and persistence. Allergy Asthma Proc. 2011;32:313–8.CrossRefPubMed Ezzat MH, Imam SS, Shaheen KY, Elbrhami EM. Serum OX40 ligand levels in asthmatic children: a potential biomarker of severity and persistence. Allergy Asthma Proc. 2011;32:313–8.CrossRefPubMed
32.
go back to reference Djuretic IM, Cruz-Guilloty F, Rao A. Chapter 1–regulation of gene expression in peripheral T Cells by Runx transcription factors. Adv Immunol. 2009;104:1–23.CrossRefPubMed Djuretic IM, Cruz-Guilloty F, Rao A. Chapter 1–regulation of gene expression in peripheral T Cells by Runx transcription factors. Adv Immunol. 2009;104:1–23.CrossRefPubMed
33.
go back to reference Li F, Wang Y, Lin L, Wang J, Xiao H, Li J, et al. Mast cell-derived exosomes promote Th2 cell differentiation via OX40L-OX40 ligation. J Immunol Res. 2016;2016:1–10. Li F, Wang Y, Lin L, Wang J, Xiao H, Li J, et al. Mast cell-derived exosomes promote Th2 cell differentiation via OX40L-OX40 ligation. J Immunol Res. 2016;2016:1–10.
34.
go back to reference Zhang Z, Zhong W, Hinrichs D, Wu X, Weinberg A, Hall M, et al. Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis. Am J Pathol. 2010;177:2912–20.CrossRefPubMedPubMedCentral Zhang Z, Zhong W, Hinrichs D, Wu X, Weinberg A, Hall M, et al. Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis. Am J Pathol. 2010;177:2912–20.CrossRefPubMedPubMedCentral
35.
go back to reference Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood. 2009;114:2639–48.CrossRefPubMed Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood. 2009;114:2639–48.CrossRefPubMed
36.
go back to reference Wong WS. Inhibitors of the tyrosine kinase signaling cascade for asthma. Curr Opin Pharmacol. 2005;5:264–71.CrossRefPubMed Wong WS. Inhibitors of the tyrosine kinase signaling cascade for asthma. Curr Opin Pharmacol. 2005;5:264–71.CrossRefPubMed
37.
go back to reference Turlej RK, Fiévez L, Sandersen CF, Dogné S, Kirschvink N, Lekeux P, et al. Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway. Thorax. 2001;56:696–702.CrossRefPubMedPubMedCentral Turlej RK, Fiévez L, Sandersen CF, Dogné S, Kirschvink N, Lekeux P, et al. Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway. Thorax. 2001;56:696–702.CrossRefPubMedPubMedCentral
38.
go back to reference Sagara H, Okada T, Okumura K, Ogawa H, Ra C, Fukuda T, et al. Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. J Allergy Clin Immunol. 2002;110:249–54.CrossRefPubMed Sagara H, Okada T, Okumura K, Ogawa H, Ra C, Fukuda T, et al. Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. J Allergy Clin Immunol. 2002;110:249–54.CrossRefPubMed
39.
go back to reference Cheng C, Ho WE, Goh FY, Guan SP, Kong LR, Lai WQ, et al. Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway. PLoS ONE. 2011;6:e20932.CrossRefPubMedPubMedCentral Cheng C, Ho WE, Goh FY, Guan SP, Kong LR, Lai WQ, et al. Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway. PLoS ONE. 2011;6:e20932.CrossRefPubMedPubMedCentral
40.
go back to reference Huang CP, Yang HP, Zhang ZX, Yong-Jian XU. Regulation of the expression of Th2 cytokines by p38MAPK in asthmatic rats. Chin J Pathophysiol. 2006;22:311–3. Huang CP, Yang HP, Zhang ZX, Yong-Jian XU. Regulation of the expression of Th2 cytokines by p38MAPK in asthmatic rats. Chin J Pathophysiol. 2006;22:311–3.
Metadata
Title
OX40L induces helper T cell differentiation during cell immunity of asthma through PI3K/AKT and P38 MAPK signaling pathway
Authors
Li Huang
Meijuan Wang
Yongdong Yan
Wenjing Gu
Xinxing Zhang
Jiahong Tan
Huiming Sun
Wei Ji
Zhengrong Chen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2018
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-018-1436-4

Other articles of this Issue 1/2018

Journal of Translational Medicine 1/2018 Go to the issue